Home
Retro Biosciences

Retro Biosciences Market Share Analysis for August 2026

Join Retro Biosciences to help build therapies that extend healthy human lifespan.

Health > Biotechnology and Pharmaceuticals

Domainretro.bio

Year Founded2021

Employees51 - 200

Annual Revenue--

Retro Biosciences

Retro Biosciences (including company regionals)

retro.bio

See more website traffic and engagement information

Total visits to Retro Biosciences's top domains

Understand Retro Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

retro.bio11.5K

See more with Sales Intelligence

Avg. visit duration in Retro Biosciences's top domains

Analyze Retro Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

retro.bio00:00:50

See more with Sales Intelligence

Avg. pageviews on Retro Biosciences's top domains

See how Retro Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

retro.bio1.79

See more with Sales Intelligence

Retro Biosciences top competitors by domain

Top similar sites in August 2026, ranked by their affinity

revance.comCompany NameRevanceEmployees1001 - 5000HQUnited States, Tennessee, NashvilleAnnual revenue$200M - $500MTotal visits17.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Retro Biosciences

These are the website technologies, by industry, used by Retro Biosciences top domains

Advertising (2)

DoubleClick

Content Management System (2)

WordPress

Email Services (2)

G Suite

Mobile (2)

Meta Viewport

More Technologies

5

See all

News & Signals from Retro Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRetro Biosciences, Inc. is developing AI model to find more effective variants of the Yamanaka factors on Jun 9th '26.Retro Biosciences, for example, is backed by Sam Altman and has partnered with OpenAI to develop an AI model to find more effective variants of the Yamanaka factors.

NewsRetro Biosciences, Inc. has valuation of $1.8B.Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion.

NewsRetro Biosciences, Inc. is developing therapies that reset key aspects of human biology.Retro's overarching ambition is to decouple aging from decline and disease by developing therapies that reset key aspects of human biology to a more youthful state and add 10 extra, healthy years to human lifespan.